VIGL
USDVigil Neuroscience Inc. Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$1.790
Kõrge
$1.820
Madal
$1.745
Maht
0.00M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
83.5M
Tööstusharu
Biotehnoloogia
Riik
United States
Kauplemisstatistika
Keskmine maht
0.24M
Börs
NMS
Valuuta
USD
52 nädala vahemik
Seotud uudised
Wedbush Maintains Outperform on Vigil Neuroscience, Lowers Price Target to $13
Wedbush analyst Laura Chico maintains Vigil Neuroscience with a Outperform and lowers the price target from $24 to $13.
HC Wainwright & Co. Maintains Buy on Vigil Neuroscience, Lowers Price Target to $14
HC Wainwright & Co. analyst Andrew Fein maintains Vigil Neuroscience with a Buy and lowers the price target from $17 to $14.
Vigil Neuroscience Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Recent Business Updates
– Announced positive data from Phase 1 clinical trial evaluating VG-3927 for potential treatment of Alzheimer's Disease (AD); plans to initiate Phase 2 clinical trial in Q3 2025 – – On track to report final analysis
Seotud aktsiad
ILPT
Industrial Logistics Properties Trust Common Shares of Beneficial Interest
ANAB
AnaptysBio Inc.
MGYR
Magyar Bancorp Inc.
SD
SandRidge Energy Inc.
FGB
First Trust Specialty Finance and Financial Opportunities Fund
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.